← Browse by Condition
Medical Condition
gastric cancer gc
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3
NCT07315854 Phase 2
Recruiting
Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
Enrollment
32 pts
Location
China
Sponsor
Beijing Friendship Hospital
NCT07366528 Phase 3
Recruiting
Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
Enrollment
387 pts
Location
China
Sponsor
Ruijin Hospital